hero section gradient
15 handpicked stocks

Market Fear

When markets get shaky, these stocks stand strong. Our professional analysts have carefully selected companies known for their stability during uncertain times, focusing on essential goods and services that people need regardless of economic conditions.

Author avatar

Han Tan | Market Analyst

Published on June 18

Your Basket's Financial Footprint

Interpretation of the Market Fear basket market capitalisation and investor takeaways.

Key Takeaways for Investors:
  • Large-cap dominance suggests lower volatility and returns that tend to track broader market moves.
  • Use as a core, diversified holding rather than a speculative trade; complements long-term allocations.
  • Expect steady, long-term value growth rather than explosive short-term gains; performance is generally gradual.
Total Market Cap
  • PG: $354.86B

  • KO: $306.39B

  • WMT: $846.88B

  • Other

About This Group of Stocks

1

Our Expert Thinking

During market turbulence, investors often seek safety in stable companies. This collection focuses on businesses that provide essential products and services with consistent demand regardless of economic conditions. These defensive stocks typically outperform during downturns while preserving capital.

2

What You Need to Know

This group includes consumer staples companies selling everyday necessities, utilities providing essential services, and gold mining stocks that traditionally serve as safe havens. These businesses tend to have steady revenue streams and often pay reliable dividends even when the broader market struggles.

3

Why These Stocks

Each company was selected for its leadership position in defensive sectors, strong fundamentals, and history of resilience during market downturns. These aren't necessarily high-growth stocks, but rather companies with proven ability to weather economic storms while continuing to deliver value to shareholders.

Why You'll Want to Watch These Stocks

🛡️

Shelter From The Storm

When markets tumble, these defensive stocks historically maintain their value better than most. They could be your portfolio's lifejacket during choppy market waters.

💰

Dividend Warriors

Many of these companies have impressive dividend track records, paying shareholders consistently even during recessions. This income stream could be especially valuable when other investments falter.

🔔

Economic Warning Signals

As uncertainty grows in global markets, these stocks are attracting smart money looking for safety. Their rising popularity often signals that institutional investors are preparing for volatility.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions